eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT
eXoZymes has entered into a partnership with Curia Global to initiate commercial-scale manufacturing of its NCT product. The program is expected to begin in Q4 2026 and establish a technical roadmap for larger-scale production in 2027.
Key figures
- Partner facilities
- ["León, Spain","Rozzano, Italy"]
- Program start quarter
- Q4 2026
- Next scale production year
- 2027
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.